GlaxoSmithKlineThe Impact of Medicines: Sustainability in Environment, Health and Safety Report 2002
Reporting Front PageDownloads
EHS 2002 home

About this report

Executive statements

Framework

Issues

Designing products for environmental sustainability

Ozone depletion

Pharmaceuticals in the environment

Biodiversity

Genetically modified organisms

Contaminated land

Occupational hazard evaluation and use of animals

Performance

Verification statement

Index

Issues
Previous
Next
 
 

Designing products for environmental sustainability
GSK aspires to be a sustainable company and recognises that moving from aspiration to reality may take years. Initially we will work toward enhancing our environmental sustainability while delivering new products faster and better. We have launched an eco-design toolkit that is primarily for new product development, but may also be of help for product transfer or redesign of processes.

Dr. Robert K. Lynn "R&D is committed to EHS as an integral part of our development process. Our primary focus at present is to improve production efficiency, which has benefits for the business and for the environment while helping the company attain its sustainability goals." Dr. Robert K. Lynn, Senior Vice President, Pre-Clinical Development , R&D

The toolkit will help GSK bring products to market faster because the eco-design principles and practices will guide scientists and engineers to design-out potential problems early in development.
It will help us bring products to market more cost effectively because eco-design principles and practices will enable GSK to use less material and energy to make our products. It enables R&D to address potential environment, safety and health issues before a process is handed over to manufacturing where the cost to address EHS issues is considerably higher.

The toolkit is currently composed of several modules. Each of these modules considers the EHS impacts of materials, processes and services from the time raw materials are extracted through to the ultimate fate of products and wastes in the environment. The modules currently available include the following:

Green Chemistry Guide - offers guidance to GSK scientists and engineers on applying Green Chemistry concepts to enable more efficient use of resources, reduce environment, health and safety impacts and minimise costs. It includes:

  • A ranking and summary of the most used chemistries and 'best-in-class' examples from well developed GSK processes.
  • A ranking and review of issues encountered during process design and development.
  • A ranking and summary of common technology alternatives for chemical processing.
  • Guidance on materials, process alternatives, synthetic route strategies and metrics for evaluating chemistries, technologies and processes.

Materials Guides
Solvent Selection - contains information on alternative solvents and solvents that should be avoided. It:

  • Compares and ranks 45 solvents according to environmental waste profile, environmental impact, safety profile and health impact.
  • Compares International Conference on Harmonisation (ICH) guidelines on allowable concentrations of solvents in active pharmaceutical ingredients against EHS characteristics of solvents.
  • Provides information on boiling point and azeotrope formation to assist in the selection of separable co-solvents.
  • Provides detailed information on physical properties, safety, health and environmental issues.

Base Selection - ranks 42 chemical bases according to their environmental waste profile, environmental impact, safety profile and health impact. It also provides detailed information on each base.

Green Packaging Guide - provides a life cycle assessment tool, guidance and a business process for selection of packaging for the Pharmaceuticals and Consumer Healthcare businesses.

Dr. Dermot Moynihan "When we develop new chemical processes, we rely on a range of technologies and predictive tools to aid and enhance process understanding and increase the speed of delivery of high quality products to GSK. We continuously develop and apply better technologies and improved ways of working to achieve a more efficient and streamlined process. This has the practical benefit of lowering costs, improving the ease and efficiency of manufacturing and reducing the consumption of natural resources and generation of waste, moving us toward our sustainable development goals. In addition to the practical benefits, it moves GSK to best in class for quality of technology and process knowledge." Dr. Dermot Moynihan, Senior Vice President, Chemical  Development, R&D

In 2002, we completed a new component of the eco-design toolkit called FLASC (Fast Lifecycle Assessment for Synthetic Chemistry). FLASC is a web-based application that allows bench chemists to perform a "life cycle" evaluation of the environmental consequences of new or existing processes based upon the input materials used. It quantifies the energy and materials used in product manufacture, as well as emissions released and potential environmental impacts.

FLASC will:

  • Facilitate the comparison or benchmark of process routes and allow chemists and managers to rapidly identify the greenest option.
  • Identify the materials that have the biggest impacts and provide guidance on how to reduce those impacts.
  • Quantify the energy and materials used in product manufacture, the emissions released, and potential environmental impacts.

FLASC is a process and tool that will enable an assessment of eight different environmental impact categories associated with materials used in a synthetic route or manufacturing process:

  • Mass of materials used
  • Energy required
  • Photochemical Ozone Creation Potential (POCP)
  • Greenhouse gas equivalents
  • Acidification
  • Eutrophication
  • Total organic carbon generated before any waste treatments
  • Oil and natural gas depletion for raw materials manufacture

FLASC uses a scoring system that enables a quick identification of areas for improvement, facilitates comparison of processes and serves as a tracking system for synthetic route or manufacturing process improvement throughout GSK.

Our second web-based application developed this year is the WRAP (Weighed Resources for Assessment of Packaging) Tool. With WRAP packaging development managers can determine if pack modification or new designs offer environmental improvement when compared with benchmarks of existing packs. The benchmarks use packaging profiles from over 200 individual packs and are also related to product type. They consist of a number of metrics that cover the product life cycle. The metrics are:

  • Manufacture of packaging
  • Mass of packaging
  • Biodegradability
  • PVC content
  • Resource depletion

Using a scoring mechanism, WRAP generates a colour-coded report that clearly shows if the pack is better or worse than the appropriate benchmark. The developer may then interactively investigate other pack options to find where improvements can be made and what is currently the best GSK example of packaging for that type of product. Scenario analysis is also possible so the developer can change elements of the pack profile and quickly see the effect on the score. The benchmarks will be updated and expanded as more data on packaging for GSK products are collected.

An application under development is a materials assessment site that will assess chemicals common to the pharmaceutical industry, other than solvents and bases. In the longer term, we envision an increasing number and variety of applications that will apply not only to R&D and manufacturing, but to commercial operations as well. We envision applications that move from merely providing information to providing expert knowledge.



Previous

Next


Top


EHS 2002 Home | Reporting Front Page | Downloads | Main Site

 
Updated July 21, 2003 - © 2005 GlaxoSmithKline - All Rights Reserved
Legal Notices - Privacy Statement